Analysts are all positive about Ascott Residence Trust (ART) with recovery gaining traction amid greater reopening measures recently.
See: Ascott Residence Trust reports RevPAU of $67 in 1QFY2022, up 22%
CGS-CIMB Research, DBS Group Research, OCBC Investment Trust and UOB Kay Hian have all kept their “add” and “buy” calls. PhillipCapital has kept its “accumulate” call, one step below “buy”.
For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)